Brief: Orgenesis To Collaborate With Educell To Conduct Clinical Validation Of Cell Therapies
14/07/2020 12:21
July 14 (Reuters) - Orgenesis Inc ORGS.O :
* ORGENESIS TO COLLABORATE WITH EDUCELL TO CONDUCT CLINICAL
VALIDATION OF CELL THERAPIES USING ORGENESIS’ PROPRIETARY POCARE
TECHNOLOGIES FOR THE GENERATION AND EXPANSION OF T-CELLS
* ORGENESIS - UNDER AGREEMENT, PARTIES PLAN TO CONDUCT
ONE/MORE
COLLABORATIVE CELL-BASED RESEARCH PROJECTS ALIGNED WITH LOCAL
MEDICAL CENTERS
Source text for Eikon: ID:nGNX1P9R0L
Further company coverage: ORGS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Orgenesis
See all newsBrief: Orgenesis Nasdaq To Delist Co'S Common Stock, Securities Trading Will Be Suspended On Oct 21
Brief: Orgenesis Announces Positive Results From A Real-World Study Of Org-101 Car-T Therapy
Brief: Orgenesis Announces Strategic Partnership With Harley Street Healthcare Group
Brief: Orgenesis Says Entered Purchase Deal With Theracell For Purchase Of 50% Outstanding Ownership Rights & Equity Interests In Theracell Laboratories Ike
Brief: Orgenesis Received Nasdaq Hearings Panel Decision Which Granted Company Until October 14 To Regain Compliance With Bid Price And Equity Rules